DRD2 variants were nominally associated with CPSP 4 months after different surgeries (Montes et al., 2015), as well as in chronic pain conditions (migraine) and substance abuse/addiction (Xu et al., 2004; Connor et al., 2007; Todt et al., 2009). The gene discussed is DRD2; the disease is substance abuse.